ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 519

Sex-Specific Regulatory T Cell Dysfunction in a Mouse Model of Sjögren Syndrome

Scott M. Lieberman1, Portia A. Kreiger2 and Gary A. Koretzky3, 1Pediatrics, Div Rheumatology, The Children's Hospital of Philadelphia, Philadelphia, PA, 2Pathology, Nemours/A.I. DuPont Hospital for Children, Wilmington, DE, 3Medicine, University Pennsylvania, Philadelphia, PA

Meeting: 2012 ACR/ARHP Annual Meeting

Keywords: Animal models, autoimmune diseases and regulatory cells, Sjogren's syndrome, T cells

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Title: Sjögren's Syndrome - Pathogenesis

Session Type: Abstract Submissions (ACR)

Background/Purpose: CD4+Foxp3+ regulatory T cells (Tregs) are a specialized population of lymphocytes which prevent autoimmunity in normal hosts. Treg dysfunction has been implicated in autoimmunity; however results are conflicting. Sjögren syndrome is an autoimmune disease characterized by destruction of lacrimal and salivary glands resulting in profound ocular and oral dryness. In the nonobese diabetic (NOD) mouse model of Sjögren syndrome, females develop earlier and more severe sialadenitis while males develop primarily dacryoadenitis. We previously reported that female NOD mice harbor a lacrimal gland-protective Treg population (Arthritis Rheum 2011;63 Suppl 10:495).  Here, we characterize the role of sex-based Treg dysfunction in the sexually dimorphic disease manifestations in our NOD mouse-based transfer model of Sjögren syndrome.

Methods: Sjögren-like disease was induced by transfer of cervical lymph node cells, either whole or depleted of the Treg-enriched CD4+CD25+ population, to lymphocyte-deficient NOD-SCID mice, which do not develop spontaneous autoimmunity. Five to seven weeks following adoptive transfer, dacryoadenitis and sialadenitis were quantified by an experienced, blinded pathologist using a standard focus score.

Results: Transfer of whole cervical lymph node cells from NOD mice to sex-matched NOD-SCID mice recapitulated sexually dimorphic features (i.e., males develop dacryoadenitis; females develop sialadenitis). Moreover, dacryoadenitis developed in female and male recipients of sex-matched donor cervical lymph node cells depleted of Tregs. Interestingly, in a male environment, female NOD donor cervical lymph node cells (not depleted of Tregs) induce dacryoadenitis; whereas, in a female environment, male NOD donor cervical lymph node cells fail to induce dacryoadenitis unless Tregs are depleted prior to transfer.

Conclusion: These data demonstrate that females harbor a population of lacrimal gland-protective Tregs that become dysfunctional in a male environment and suggest that dacryoadenitis in males is due to an underlying lacrimal gland-specific Treg defect. Studies to identify the sex-specific factors responsible for these findings are underway.


Disclosure:

S. M. Lieberman,
None;

P. A. Kreiger,
None;

G. A. Koretzky,

Rigel Pharmaceuticals,

5.

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2012 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/sex-specific-regulatory-t-cell-dysfunction-in-a-mouse-model-of-sjogren-syndrome/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology